
Samantha L. Shterengarts
Examiner (ID: 2, Phone: (571)270-5316 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 4131, 1623, 1626 |
| Total Applications | 2313 |
| Issued Applications | 1786 |
| Pending Applications | 96 |
| Abandoned Applications | 469 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18341851
[patent_doc_number] => 11639325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-02
[patent_title] => Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders
[patent_app_type] => utility
[patent_app_number] => 17/116427
[patent_app_country] => US
[patent_app_date] => 2020-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 36
[patent_no_of_words] => 11491
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17116427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/116427 | Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders | Dec 8, 2020 | Issued |
Array
(
[id] => 17035028
[patent_doc_number] => 20210251986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE
[patent_app_type] => utility
[patent_app_number] => 17/108101
[patent_app_country] => US
[patent_app_date] => 2020-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11462
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17108101
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/108101 | POLYMORPHIC FORMS OF 1-[4-(5-CYANOINDOL-3-YL)BUTYL]-4-(2-CARBAMOYLBENZOFURAN-5-YL) PIPERAZINE HYDROCHLORIDE | Nov 30, 2020 | Abandoned |
Array
(
[id] => 18065497
[patent_doc_number] => 20220396584
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-15
[patent_title] => BIOTIN-CONTAINING MONOMERS AND ARTICLES FORMED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/755946
[patent_app_country] => US
[patent_app_date] => 2020-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13018
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17755946
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/755946 | BIOTIN-CONTAINING MONOMERS AND ARTICLES FORMED THEREFROM | Nov 22, 2020 | Issued |
Array
(
[id] => 18215203
[patent_doc_number] => 11590116
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-28
[patent_title] => Substituted pyridines and methods of use
[patent_app_type] => utility
[patent_app_number] => 16/949915
[patent_app_country] => US
[patent_app_date] => 2020-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60905
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 453
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16949915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/949915 | Substituted pyridines and methods of use | Nov 19, 2020 | Issued |
Array
(
[id] => 17945709
[patent_doc_number] => 20220332726
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => NITROXIDE DERIVATIVE OF ROCK KINASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/298676
[patent_app_country] => US
[patent_app_date] => 2020-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34212
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298676
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298676 | NITROXIDE DERIVATIVE OF ROCK KINASE INHIBITOR | Nov 17, 2020 | Abandoned |
Array
(
[id] => 18093051
[patent_doc_number] => 20220411392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => Amide Derivative And Preparation Method Therefore And Use Thereof In Medicine
[patent_app_type] => utility
[patent_app_number] => 17/776513
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50575
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17776513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/776513 | Amide derivative and preparation method therefore and use thereof in medicine | Nov 11, 2020 | Issued |
Array
(
[id] => 16671218
[patent_doc_number] => 20210059981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/095876
[patent_app_country] => US
[patent_app_date] => 2020-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27343
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17095876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/095876 | COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS | Nov 11, 2020 | Abandoned |
Array
(
[id] => 18149511
[patent_doc_number] => 20230023368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => FUNCTIONALLY MODIFIED MAYTANSINOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/774843
[patent_app_country] => US
[patent_app_date] => 2020-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -57
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17774843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/774843 | FUNCTIONALLY MODIFIED MAYTANSINOIDS AND COMPOSITIONS AND METHODS OF USE THEREOF | Nov 4, 2020 | Pending |
Array
(
[id] => 18427583
[patent_doc_number] => 11672782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Carboxamide derivatives
[patent_app_type] => utility
[patent_app_number] => 17/089064
[patent_app_country] => US
[patent_app_date] => 2020-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32689
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 224
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17089064
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/089064 | Carboxamide derivatives | Nov 3, 2020 | Issued |
Array
(
[id] => 16628632
[patent_doc_number] => 20210047285
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => Method for Aerobic Oxidative Coupling of Thiophenes with a Ligand-Supported Palladium Catalyst
[patent_app_type] => utility
[patent_app_number] => 17/087926
[patent_app_country] => US
[patent_app_date] => 2020-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13442
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17087926
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/087926 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | Nov 2, 2020 | Issued |
Array
(
[id] => 16628645
[patent_doc_number] => 20210047298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => GLP-1 RECEPTOR AGONISTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/085534
[patent_app_country] => US
[patent_app_date] => 2020-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 332
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17085534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/085534 | GLP-1 receptor agonists and uses thereof | Oct 29, 2020 | Issued |
Array
(
[id] => 18244124
[patent_doc_number] => 20230076435
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/754837
[patent_app_country] => US
[patent_app_date] => 2020-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17754837
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/754837 | MODIFIER OF FOUR-MEMBERED RING DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF | Oct 28, 2020 | Pending |
Array
(
[id] => 18093036
[patent_doc_number] => 20220411377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/770352
[patent_app_country] => US
[patent_app_date] => 2020-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17770352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/770352 | SELECTIVE NEURONAL NITRIC OXIDE SYNTHASE INHIBITORS | Oct 25, 2020 | Pending |
Array
(
[id] => 16870026
[patent_doc_number] => 20210163493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => HETEROARYL AMIDE COMPOUNDS AS STING ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 17/079094
[patent_app_country] => US
[patent_app_date] => 2020-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17079094
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/079094 | Heteroaryl amide compounds as sting activators | Oct 22, 2020 | Issued |
Array
(
[id] => 18259730
[patent_doc_number] => 11607416
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-03-21
[patent_title] => Bicyclic heterocycles as FGFR inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/070160
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76689
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1883
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070160
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070160 | Bicyclic heterocycles as FGFR inhibitors | Oct 13, 2020 | Issued |
Array
(
[id] => 19112650
[patent_doc_number] => 20240124400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/768152
[patent_app_country] => US
[patent_app_date] => 2020-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33728
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768152
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768152 | LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | Oct 11, 2020 | Pending |
Array
(
[id] => 18202346
[patent_doc_number] => 11584728
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-02-21
[patent_title] => Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia
[patent_app_type] => utility
[patent_app_number] => 17/062339
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 15
[patent_no_of_words] => 83664
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 387
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062339 | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia | Oct 1, 2020 | Issued |
Array
(
[id] => 18102361
[patent_doc_number] => 11542236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-03
[patent_title] => Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same
[patent_app_type] => utility
[patent_app_number] => 17/038497
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 15756
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17038497
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/038497 | Sulfonyldiazoles and N-(fluorosulfonyl)azoles, and methods of making the same | Sep 29, 2020 | Issued |
Array
(
[id] => 16976143
[patent_doc_number] => 20210220380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => AMINOGLYCOSIDE DERIVATIVES AND USES THEREOF IN TREATING GENETIC DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/032954
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18097
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17032954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/032954 | Aminoglycoside derivatives and uses thereof in treating genetic disorders | Sep 24, 2020 | Issued |
Array
(
[id] => 18127976
[patent_doc_number] => 11554172
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-17
[patent_title] => Phosphonate linkers and their use to facilitate cellular retention of compounds
[patent_app_type] => utility
[patent_app_number] => 17/031249
[patent_app_country] => US
[patent_app_date] => 2020-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27583
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 287
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17031249
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/031249 | Phosphonate linkers and their use to facilitate cellular retention of compounds | Sep 23, 2020 | Issued |